ADS Biotec is part of a dedicated global network joined together to stop the COVID-19 pandemic. Throughout our organization, we are committed to delivering SARS-CoV-2 diagnostic test solutions to hospitals, labs, clinics, pharmacies and other health and community-based organizations.

Our mission is to protect frontline workers, patients and all those in our communities affected by this fast-evolving pandemic — and share our knowledge, our resources and our trusted technologies based on 20+ years of advanced industry experience — to help deliver the critically important diagnostic results required.

We offer a range of effective and highly reliable COVID-19 serology and antigen test solutions, including SARS-CoV-2 IgM/IgG Antibody Test Kits (colloidal gold), SARS-CoV-2 Antigen Rapid Tests (colloidal gold and fluorescence immunochromatography methods), ELISA Antigen Quantitative Assays, and RNA Viral Extraction Kits, based on nasal, throat and nasopharyngeal swab sample types.

SARS-CoV-2 IgM/IgG Antibody Test Kit (Colloidal Gold Method) is authorized by the FDA Emergency Use Authorization (EUA)/(Antibody) and the European Union CE-IVD (Antibody detection and Antigen detection). All other ADS Biotec SARS-CoV-2 diagnostic and detection test kits are only authorized by the European Union CE-IVD (Antibody detection and Antigen detection).  All are backed by our company’s full commitment to continued supply, service and support.

For full integration and efficient high-volume processing, select from ADS Biotec automated systems including the QuickGene 24S and QuickGene 12S Nucleic Acid Extraction Systems. Plus, our QuickGene AutoS RNA Extraction Virus Kit is ideal for extracting high quality RNA for SARS-CoV-2 test applications.